Free Trial

3M (MMM) Competitors

3M logo
$145.01 +0.78 (+0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$145.30 +0.29 (+0.20%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MMM vs. DHR, CSL, BSX, SYK, BDX, RMD, DXCM, PODD, WST, and BAX

Should you be buying 3M stock or one of its competitors? The main competitors of 3M include Danaher (DHR), Carlisle Companies (CSL), Boston Scientific (BSX), Stryker (SYK), Becton, Dickinson and Company (BDX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), West Pharmaceutical Services (WST), and Baxter International (BAX).

3M vs.

Danaher (NYSE:DHR) and 3M (NYSE:MMM) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, Danaher had 16 more articles in the media than 3M. MarketBeat recorded 34 mentions for Danaher and 18 mentions for 3M. 3M's average media sentiment score of 1.61 beat Danaher's score of 1.54 indicating that 3M is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
31 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Very Positive
3M
18 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Danaher pays an annual dividend of $1.28 per share and has a dividend yield of 0.6%. 3M pays an annual dividend of $2.92 per share and has a dividend yield of 2.0%. Danaher pays out 24.9% of its earnings in the form of a dividend. 3M pays out 36.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has increased its dividend for 2 consecutive years and 3M has increased its dividend for 1 consecutive years.

Danaher received 161 more outperform votes than 3M when rated by MarketBeat users. Likewise, 74.22% of users gave Danaher an outperform vote while only 59.25% of users gave 3M an outperform vote.

CompanyUnderperformOutperform
DanaherOutperform Votes
1074
74.22%
Underperform Votes
373
25.78%
3MOutperform Votes
913
59.25%
Underperform Votes
628
40.75%

Danaher has a net margin of 16.33% compared to 3M's net margin of 15.71%. 3M's return on equity of 100.77% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher16.33% 10.82% 6.90%
3M 15.71%100.77%9.84%

79.1% of Danaher shares are owned by institutional investors. Comparatively, 65.3% of 3M shares are owned by institutional investors. 11.1% of Danaher shares are owned by company insiders. Comparatively, 0.3% of 3M shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

3M has higher revenue and earnings than Danaher. 3M is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$23.82B5.99$3.90B$5.1538.69
3M$24.51B3.17$4.17B$7.9218.21

Danaher has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, 3M has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500.

Danaher currently has a consensus target price of $248.17, indicating a potential upside of 24.55%. 3M has a consensus target price of $153.46, indicating a potential upside of 6.39%. Given Danaher's stronger consensus rating and higher probable upside, equities analysts clearly believe Danaher is more favorable than 3M.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.80
3M
2 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.57

Summary

Danaher beats 3M on 13 of the 21 factors compared between the two stocks.

Get 3M News Delivered to You Automatically

Sign up to receive the latest news and ratings for MMM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MMM vs. The Competition

Metric3MSurgical & medical instruments IndustryMulti-Sector SectorNYSE Exchange
Market Cap$77.96B$4.38B$13.89B$19.76B
Dividend Yield1.99%42.68%3.91%3.85%
P/E Ratio19.1928.5925.4835.64
Price / Sales3.1871.663.3646.10
Price / Cash14.9051.0813.3517.51
Price / Book20.205.962.144.84
Net Income$4.17B$67.01M$959.43M$1.02B
7 Day Performance-2.30%6.04%0.06%2.29%
1 Month Performance1.84%21.72%5.24%5.80%
1 Year Performance43.96%21.45%-5.23%14.66%

3M Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MMM
3M
4.4165 of 5 stars
$145.01
+0.5%
$153.46
+5.8%
+43.0%$78.04B$24.51B19.2192,000Positive News
DHR
Danaher
4.8556 of 5 stars
$199.97
+2.0%
$263.24
+31.6%
-24.3%$143.13B$23.82B37.8881,000Positive News
Analyst Downgrade
CSL
Carlisle Companies
4.4181 of 5 stars
$380.73
+0.7%
$454.00
+19.2%
-7.2%$16.47B$5.00B13.7812,500
BSX
Boston Scientific
4.6258 of 5 stars
$100.85
-1.2%
$116.00
+15.0%
+29.7%$149.30B$17.55B80.7345,000Positive News
SYK
Stryker
4.8739 of 5 stars
$383.50
-0.1%
$427.30
+11.4%
+9.4%$146.37B$23.22B49.4251,000Positive News
BDX
Becton, Dickinson and Company
4.9789 of 5 stars
$173.53
+0.6%
$219.22
+26.3%
-28.3%$49.73B$20.87B28.8277,000Positive News
RMD
ResMed
4.0589 of 5 stars
$252.00
-0.1%
$259.33
+2.9%
+19.0%$36.95B$5.02B29.758,160Positive News
DXCM
DexCom
4.769 of 5 stars
$86.18
-0.6%
$98.32
+14.1%
-26.0%$33.85B$4.15B60.377,600Positive News
PODD
Insulet
4.1153 of 5 stars
$307.09
-1.5%
$318.41
+3.7%
+59.7%$21.61B$2.20B53.032,600Positive News
WST
West Pharmaceutical Services
4.8031 of 5 stars
$225.09
+0.2%
$332.50
+47.7%
-28.9%$16.18B$2.90B33.6510,700Trending News
BAX
Baxter International
4.6411 of 5 stars
$31.02
+2.5%
$37.25
+20.1%
-6.9%$15.89B$10.77B-24.1960,000Positive News
Options Volume

Related Companies and Tools


This page (NYSE:MMM) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners